Soliton (SOLY +10%) is up on average volume in apparent reaction to today’s announcement that preliminary data from a proof-of-concept study
evaluating its acoustic shock wave technology for the treatment of
keloid and hypertrophic scars will be presented on Thursday, October 24,
at the American Society of Dermatologic Surgery Annual Meeting in
Chicago followed by a webcast on Friday, October 25 at 5:30 pm ET.
https://seekingalpha.com/news/3507312-soliton-10-percent-ahead-key-data-readout
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.